Correction: Transcriptome profiling analysis reveals that CXCL2 is involved in anlotinib resistance in human lung cancer cells
Saved in:
Published in | BMC medical genomics Vol. 15; no. 1; pp. 1 - 155 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central Ltd
08.07.2022
BioMed Central BMC |
Online Access | Get full text |
Cover
Loading…
Bibliography: | correction SourceType-Other Sources-1 content type line 63 ObjectType-Correction/Retraction-1 |
---|---|
ISSN: | 1755-8794 1755-8794 |
DOI: | 10.1186/s12920-022-01309-6 |